In the spring of 2014, a small Michigan biotech closed a $6.5 million deal to buy several cell therapies from the French drug giant Sanofi. They included a technology to treat weekend warriors with worn-out knees and a new kind of skin graft for people with catastrophic burns. Almost exactly five years later, the acquisitions […]

Cambridge-based cell therapy firm Vericel Corp. has forged a $142 million deal to license a gel used to help heal burns that made just over $3 million in sales last year at an Israeli company. Vericel (Nasdaq: VCEL) will pay $17.5 million upfront and up to $125 million in milestones to license and sell the burn repair product NexoBrid […]

Not everyone heading to Atlanta for the Super Bowl is focusing entirely on the big game. Some are turning the spotlight on medical breakthroughs, and harnessing the power of sports to tackle injury. Former pro football player and sportscaster Solomon Wilcots has the play by play on a new cell therapy developed by Vericel to […]